Bharat Biotech's Covaxin Covid-19 Vaccine Shows 77.8% Efficacy in Phase 3 Trials

Covaxin's Phase 3 trial data which has shown 77.8% efficacy was approved by the Subject Expert Committee (SEC) under DCGI on Tuesday.

from Top India News- News18.com https://ift.tt/3qhQs5g